stoxline Quote Chart Rank Option Currency Glossary
Axonics, Inc. (AXNX)
67.02  0.01 (0.01%)    05-30 15:08
Open: 67.01
High: 67.175
Volume: 206,996
Pre. Close: 67.01
Low: 66.92
Market Cap: 3,419(M)
Technical analysis
2024-05-30 2:42:30 PM
Short term     
Mid term     
Targets 6-month :  78.6 1-year :  79.31
Resists First :  67.3 Second :  67.91
Pivot price 67.39
Supports First :  66.31 Second :  55.17
MAs MA(5) :  67.13 MA(20) :  67.38
MA(100) :  67.82 MA(250) :  60.35
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  16.3 D(3) :  22
RSI RSI(14): 40.5
52-week High :  69.68 Low :  47.7
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ AXNX ] has closed above bottom band by 5.4%. Bollinger Bands are 75.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 27 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 67.44 - 67.91 67.91 - 68.27
Low: 65.61 - 66.26 66.26 - 66.76
Close: 66.12 - 66.99 66.99 - 67.66
Company Description

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Headline News

Wed, 29 May 2024
Artisan Partners Limited Partnership Increases Stake in Axonics, Inc. (NASDAQ:AXNX) - MarketBeat

Wed, 29 May 2024
Artisan Small Cap Fund Exited Axonics (AXNX) on an Acquisition Announcement - Yahoo Finance

Tue, 28 May 2024
Axonics, Inc. (NASDAQ:AXNX) Shares Purchased by Dimensional Fund Advisors LP - MarketBeat

Tue, 28 May 2024
Dimensional Fund Advisors LP Purchases 56418 Shares of Axonics, Inc. (NASDAQ:AXNX) - Defense World

Mon, 27 May 2024
Axonics (AXNX) Soars 10.6%: Is Further Upside Left in the Stock? - Yahoo Movies UK

Sun, 26 May 2024
Axonics Modulation Technologies (AXNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ... - Yahoo Lifestyle UK

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Devices
Shares Out 51 (M)
Shares Float 50 (M)
Held by Insiders 1 (%)
Held by Institutions 101.3 (%)
Shares Short 3,410 (K)
Shares Short P.Month 3,440 (K)
Stock Financials
EPS -0.32
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 12.28
Profit Margin -4.2 %
Operating Margin -16.8 %
Return on Assets (ttm) -0.7 %
Return on Equity (ttm) -2.7 %
Qtrly Rev. Growth 29.3 %
Gross Profit (p.s.) 0
Sales Per Share 7.58
EBITDA (p.s.) 0.1
Qtrly Earnings Growth 0 %
Operating Cash Flow -10 (M)
Levered Free Cash Flow -7 (M)
Stock Valuations
PE Ratio -216.17
PEG Ratio 20.4
Price to Book value 5.45
Price to Sales 8.83
Price to Cash Flow -326.54
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android